Impact BioMedical, Inc. (IBO)
:IBO
Total Valuation
Impact BioMedical, Inc. has a market cap or net worth of ―. The enterprise value is $7.38M.
Market Cap―
Enterprise Value$7.38M
Share Statistics
Impact BioMedical, Inc. has 107,821,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding107,821,230
Owned by Insiders0.74%
Owned by Institutions0.03%
Financial Efficiency
Impact BioMedical, Inc.’s return on equity (ROE) is -0.94 and return on invested capital (ROIC) is -21.59%.
Return on Equity (ROE)-0.94
Return on Assets (ROA)-0.68
Return on Invested Capital (ROIC)-21.59%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee16.00K
Profits Per Employee0.00
Employee Count2
Asset Turnover<0.01
Inventory Turnover24.90
Valuation Ratios
The current PE Ratio of Impact BioMedical, Inc. is ―. Impact BioMedical, Inc.’s PEG ratio is -0.00036.
PE Ratio―
PS Ratio497.91
PB Ratio1.26
Price to Fair Value1.26
Price to FCF-8.43
Price to Operating Cash Flow-15.41
PEG Ratio-0.00036
Income Statement
In the last 12 months, Impact BioMedical, Inc. had revenue of 32.00K and earned -11.84M in profits. Earnings per share was -0.38.
Revenue32.00K
Gross Profit-1.54M
Operating Income-4.27M
Pretax Income-14.45M
Net Income-11.84M
EBITDA-3.13M
Earnings Per Share (EPS)-0.38
Cash Flow
In the last 12 months, operating cash flow was -1.21M and capital expenditures 0.00, giving a free cash flow of -1.21M billion.
Operating Cash Flow-1.21M
Free Cash Flow-1.21M
Free Cash Flow per Share-0.01
Dividends & Yields
Impact BioMedical, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.09
52-Week Price Change-32.03%
50-Day Moving Average0.51
200-Day Moving Average0.56
Relative Strength Index (RSI)53.92
Average Volume (3m)174.82K
Important Dates
Impact BioMedical, Inc. upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Impact BioMedical, Inc. as a current ratio of 0.35, with Debt / Equity ratio of 0.00%
Current Ratio0.35
Quick Ratio0.30
Debt to Market Cap0.00
Net Debt to EBITDA<0.01
Interest Coverage Ratio-5.38
Taxes
In the past 12 months, Impact BioMedical, Inc. has paid -2.58M in taxes.
Income Tax-2.58M
Effective Tax Rate0.18
Enterprise Valuation
Impact BioMedical, Inc. EV to EBITDA ratio is -5.10, with an EV/FCF ratio of -8.43.
EV to Sales497.81
EV to EBITDA-5.10
EV to Free Cash Flow-8.43
EV to Operating Cash Flow-8.43
Balance Sheet
Impact BioMedical, Inc. has $3.00K in cash and marketable securities with $0.00 in debt, giving a net cash position of $3.00K billion.
Cash & Marketable Securities$3.00K
Total Debt$0.00
Net Cash$3.00K
Net Cash Per Share<$0.01
Tangible Book Value Per Share-$0.05
Margins
Gross margin is -4803.13%, with operating margin of -13343.75%, and net profit margin of -36993.75%.
Gross Margin-4803.13%
Operating Margin-13343.75%
Pretax Margin-45156.25%
Net Profit Margin-36993.75%
EBITDA Margin-9765.63%
EBIT Margin-13343.75%
Analyst Forecast
The average price target for Impact BioMedical, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―